Related Experiment Videos
Metabolic effects of theophylline in preterm infants
The Journal of Pediatrics
|May 1, 1981
Insights
A loading dose of theophylline, a medication used for infants, can alter blood glucose and insulin levels. Long-term effects on infant metabolism require further investigation to prevent potential issues.
Area of Science:
- Neonatal medicine
- Pharmacology
- Endocrinology
Background:
- Theophylline is frequently used in premature infants.
- Metabolic effects of acute theophylline administration are partially understood.
- Chronic metabolic impact remains uncharacterized.
Purpose of the Study:
- To investigate the chronic effects of theophylline on metabolic parameters in premature infants.
- To assess the long-term impact of theophylline on glucose, insulin, and glucagon levels.
Main Methods:
- This study focuses on the known acute effects and unknown chronic effects of theophylline.
- Observational data on premature infants receiving theophylline is considered.
Main Results:
- A loading dose of theophylline causes significant metabolic changes.
- Increased plasma glucose and early serum insulin rise observed in some infants.
Conclusions:
- The chronic effects of theophylline on infant metabolism are currently unknown.
- Potential for metabolic derangements necessitates caution during prolonged theophylline use in premature infants.
Abstract:
A loading dose of theophylline produces significant metabolic changes, including increase of plasma glucose concentration and an early rise in serum insulin in some infants. The chronic effects of theophylline on plasma glucose, serum insulin, and glucagon are not known at this time. The potential for development of metabolic derangements must be kept in mind when theophylline is used for protracted periods in premature infants.